palliative-clinical-trials-2019-keynote

Page 45

Notes:

allied

academies

Journal of Research and Reports in Gynecology and Obstetrics | Volume: 3

February 28-March 01, 2019 | Paris, France

Palliative Care, Obstetrics and Gynecology

Stroke and Clinical Trials

International Conference on

Joint Event on

International Conference on

linical trials are key to advancing evidence-based medical

research, one of the pillars of the evidence-based

medicine widely used to treat patient. While regulation is

needed to ensure the conduct of clinical trials in compliance

with ethical standards, with clear scientific proof and benefit

overweigh risk to protect patient, fake trials and (subsequent)

wrong publications can lead to wrong or ineffective or

harmful molecules being brought in the market, hence have

an impact on patient health. A literature review has been

performed to identify situations where omitted data, altered

data, manufactured data, misinterpretation of data and

provision of wrong information were reported; solutions to

address these situations have been also sought.

Speaker Biography

Danielle IWANDZA is the founder and CEO of PharmaCqARE, a cabinet providing

drug-related counsel, training and services for pharmaceutical companies, authorities

and healthcare professionals; she has 21 years of experience in the European

pharmaceutical industry. She has been an independent pharmacovigilance senior

consultant for 7 years, providing her services to medium sized and big pharma

companies in France, Germany, Switzerland and The Netherlands. Prior to that, she had

growing pharmacovigilance responsibilities and has been head of pharmacovigilance

in France for a big pharma company and pharmacovigilance head & EU-QPPV for a

hospital generic company. She was previously physician clinical research for 3 years

and prior to that had been a medical practitioner in hospitals and clinics in the south

of France. She graduated in the specialty of dermatology from the University of

Montpellier in France. She also holds a clinical research degree from Sup’Santé school

in Paris and a pharmacoepidemiology degree from the Bordeaux school of Pharmacy.

Danielle IWANDZA

PharmaCqARE, France

How fake clinical trials impact patient safety

Danielle IWANDZA

, Res Rep Gynaecol Obstet, Volume 3

DOI: 10.4066/2591-7366-C1-001